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We report a case of recurrent cutaneous necrotizing eosinophilic vasculitis (RCNEV) in a 57-year-old male.
The patient presented with papules and pruritus of the lower limbs of more than 1 month duration, and with
angioedema and intensively pruritic, necrotizing lesions of the bilateral anterior tibias and feet for 2 weeks.
Treatment with systemic corticosteroids was administered for 1 month, and resulted in a significant improvement.
We also present a review of the pertinent literature and discuss the clinical features, histopathological features, and
differentiation of RCNEV.
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Recurrent cutaneous necrotizing eosinophilic vasculitis
is a rare disease, which has clinical features of annular
urticarial plaques, pruritic purpuric papules, angioe-
dema, long course, chronic relapsing process, and an
absence of any features of the systemic disease. Histo-
pathological findings of RCNEV show necrotizing vascu-
litis of dermal small vessels with prominent eosinophilic
infiltration. RCNEV was first reported by Chen, in 1994,
and to the best of our knowledge there are only five pa-
tients with RCNEV described in the literature. Peripheral
blood eosinophilia is a feature of many diseases such as
hypereosinophilic syndrome, Wells syndrome, Churg-
Strauss syndrome, and eosinophilic fasciitis. Compared
with the aforementioned diseases, RCNEV has distinct
pathological features of fibrinoid degeneration on small
vessel walls and necrotizing vasculitis of dermal small
vessels with prominent eosinophilic infiltration. Here,
we report a case of RCNEV in a 57-year-old male, whose
diagnosis was made using clinical, histopathological, and* Correspondence: Xinmeilu2013@163.com
1Shandong Provincial Hospital for Skin Diseases, Shandong University, Jinan
250022, China
2Shandong Provincial Institute of Dermatology and Venereology, Jinan
250022, China
Full list of author information is available at the end of the article
© 2013 Li et al.; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the orlaboratory analysis results, and who was treated using
systemic corticosteroids.Case presentation
A 57-year-old Chinese male complained of papules and
pruritus of the lower limbs for more than 1 month, and
angioedema with intensively pruritic, necrotizing lesions
of the bilateral anterior tibias and feet for 2 weeks. Se-
veral needlepoint-sized papules appeared on his lower
limbs, and the patient was treated for “eczema”. How-
ever, the skin lesions increased, with itchy needlepoint-
to millet-sized papules appearing on the anterior tibias.
Three weeks later, lesions of the lower extremities exa-
cerbated, papules merged into purpuric plaques with
angioedema, and some lesions became necrotic. Labora-
tory examinations and a skin biopsy were recommended.
He was a farmer , and lived in a small village. He had no
history of smoking, drinking and potential exposure to
dust. No potential anomalies in nutrition. He did not
have a family history of dermatoses, allergic rhinitis, or
asthma. He denied a history of insect bites and drug
eruption, but had more than five years history of psoriasis.
Physical examination showed that necrotizing lesions, pla-
ques of purpuric angioedema, and excoriation were pre-
dominantly localized on the lower limbs (Figure 1). He didhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Typical rash showing necrotizing lesions, plaques of purpuric angioedema, and excoriations predominantly localized on the
lower limbs. A skin biopsy was performed from the area indicated by the arrow. A: Necrotizing lesions and plaques of purpuric angioedema on
the bilateral lower legs and the tops of feet. B: Excoriations on the plaque of purpuric angioedema.
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was normal. Electrocardiogram, chest X-ray, abdominal
ultrasound, and cranial computed tomography investiga-
tions indicated no cardiac, pulmonary, hepatic, splenic,
nephritic, central nervous system, maxillary sinus, or other
visceral organ involvement.
Additional laboratory analysis revealed: white blood
cell count 11.8×109/l with 28.7% eosinophils (3.4 × 109/l;
normal 0.05-0.5 × 109/l); elevated erythrocyte sedimen-
tation rate (32 mm/h; normal 0–15 mm/h); elevated
C-reactive protein level (14.5 mg/1; normal 0–8.2 mg/1);
negative antistreptolysin O titer and rheumatoid factor;
elevated serum immunoglobulin E level (658.3 IU/ml;
normal 0–100 IU/ml); normal serum immunoglobulins
G, M, and A levels; normal liver enzyme level; abnormal
alkaline phosphatase (131 U/l; normal 26–117 U/l);
negative anti-neutrophil cytoplasmic antibodies(ANCA;
MPO-ANCA 9 Ru/ml; normal 0–20 Ru/ml. PR3-ANCA
7 Ru/ml; normal 0–20 Ru/ml.); negative antinuclear;
negative HIV and syphilis antibodies; normal hepatitis A,
B, and C serology; hemolytic complement results con-
sistent with inflammation (C3 1260 mg/1; normal
900–1800 mg/1, C4 430 mg/1; normal 100–400 mg/1);
normal urine analysis; and stool examinations negative forparasites and ova. A skin biopsy was performed from a
purpuric angioedema lesion on the right limb, providing a
specimen of about 1.0 cm × 0.5 cm × 0.7 cm. It revealed a
normal epidermis and an infiltration consisting of numer-
ous eosinophils and a few neutrophils perivascular, into
vessel walls, in the upper and deep dermis, and in the sub-
cutaneous tissue. Thickening of the vessel walls, nu-
merous extravascular erythrocytes, fibrin thrombi in
the lumens, and fibrinoid degeneration (Figures 2, 3, 4, 5)
were noted. The diagnosis of RCNEV was made.
The patient was initially treated with 1 mg/kg pred-
nisone daily, compound glycyrrhizin 150 mg daily. Mu-
pirocin ointment was applied to the necrotic lesions.
Immediate improvements in clinical manifestations and
inflammation were noted. After 2 days, intensive pru-
ritus and angioedema decreased rapidly. After 7 days,
pruritus and angioedema had disappeared, and labo-
ratory examinations showed that white blood cell and
eosinophil cell count had normalized. One month later,
the necrotizing lesions healed, with some remaining as
superficial scars. The dose of prednisone was then slowly
decreased. All hematological and biochemical examina-
tions were normal and no new lesions were noticed after
4 months of follow-up. As any attempts to discontinue
Figure 2 Normal epidermis and the infiltration of numerous
inflammatory cells in the upper and deep dermis. Thickening of
the vessel walls and infiltration of inflammatory cells perivascular
and into vessel walls (H&E × 100).
Figure 4 The infiltration consists of numerous eosinophils and
a few neutrophils perivascular, into vessel walls, and in the
subcutaneous tissue. Numerous extravascular erythrocytes and
fibrin thrombi in the lumens (H&E × 200).
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presently continues to take prednisone at a dose of
10 mg daily.
Discussion
Chen et al. [2] reported one male and two female pa-
tients diagnosed with RCNEV. The male patient, a 17-
year-old in 1973, noted purpuric lesions on his feet and
buttocks, which later involved his entire body. One of
the two females was a 56-year-old woman in 1989, and
presented with pruritic purpuric lesions of 6-monthFigure 3 The infiltration consists of numerous eosinophils and
a few neutrophils perivascular, into vessel walls. Numerous
extravascular erythrocytes and fibrin thrombi in the lumens
(H&E × 200).duration. Another woman, at the age of 18 years in
1967, presented with gingivitis, pruritic, erythematous,
and purpuric papules, and angioedema of the hands.
Skin biopsy specimens showed a common feature: nec-
rotizing vasculitis with marked perivascular eosinophil
infiltration. In 2000, Launay et al. [3] reported one patient
who was an 81-year-old woman in 1996 who presented
with intensively itchy, infiltrating, necrotic purpuric le-
sions on the lower limbs for 2 weeks. Skin biopsy wasFigure 5 Fibrinoid degeneration and the infiltration consisting
of numerous eosinophils and a few neutrophils perivascular
and into vessel walls (H&E × 400).
Table 1 Clinicopathological features of HES, Wells syndrome, CSS and EF HES
HES Wells syndrome CSS EF
Sex ratio (M:F) 9.1 1:1 1:1 2:1
Age HES can happen at any age,
although it is more common
in adults
Wells syndrome usually affects adults CSS can present at any age,
with the mean age of onset
being 40 years
EF usually affects adults
between 20 and
60 years
Clinical features Skin rashes such as urticaria or
angioedema
Urticaria, cellulitis, annular plaques
vesiculo-bullous lesions and edema
Hypereosinophilia, asthma,
pulmonary infiltrates, and
clinical evidence of vasculitis
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vasculitis
Eosinophilic infiltrates and flame
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perivascular eosinophilic infiltration in



















Clinical outcome More than 80% of HES
patients survive five years or
more
It tends to resolve in weeks or
months, usually without scarring. It
occasionally recurs. In these recurrent
cases, it can take years to ultimately
resolve
The mean five years mortality
rate is 28%
The prognosis is usually
good in the case of an
early treatment if there
is no visceral
involvement
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ing vasculitis in the deep dermis with striking infiltration
by eosinophils. In 2007, Tanglertsampan et al. [1] reported
a 53-year-old white male diagnosed with RCNEV. He was
treated with indomethacin, with a favorable response.
The pathogenesis of RCNEV is not fully understood,
but cytotoxic eosinophil granule proteins such as major
basic proteins are found to deposit in the areas of blood
vessels, suggesting that eosinophils mediate vascular da-
mage in this disease process [3,4]. Eosinophils release
IL-5, C4, and platelet-activating factor, which may lead
to increased vascular permeability and induce cutaneous
lesions such as purpuric papules and angioedema [5,6].
Although he had more than five years history of psoriasis,
no evidence confirmed a correlation between psoriasis
and RCNEV.
A review of the literature has demonstrated that per-
ipheral blood eosinophilia is related to many dermatoses
such as hypereosinophilic syndrome(HES), wells syn-
drome,or eosinophilic cellulitis, Churg-Strauss syndrome
(CSS) and Eosinophilic fasciitis (EF) [7-13]. Clinico-
pathological features of these diseases are listed in
Table 1.
In our case, not only an exclusive clinical histopatho-
logical feature of fibrinoid degeneration of small vessel
walls, but also necrotizing vasculitis of dermal small ves-
sels with prominent infiltration of eosinophils strongly
supported the diagnosis of RCNEV.
With regard to the treatment of RCNEV, systemic
corticosteroids are most commonly selected because of
their effectiveness. Immediate improvements in clinical
manifestations and inflammation were noted in our pa-
tient following the administration of prednisone. However,some measures should be taken to avoid its side effects if
it is used persistently. Compound glycyrrhizin can reduce
the activity of T-lymphocyte subset and play an anti-
inflammatory role [14]. Mupirocin ointment was used to
prevent or control local infection of necrotic lesions. This
therapeutic regimen proved to be suitable in our patient,
and we consequently obtained a good clinical outcome.
Conclusion
RCNEV is rare and has clinical and histopathological
features, which are different to other conditions of
hypereosinophilia and eosinophilic vasculitis. Systemic
corticosteroid is very effective in the treatment of
RCNEV.
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